BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3069709)

  • 1. The efficacy of a cell-mediated reaction in the disposal of M. leprae in human skin.
    Kaplan G
    Immunol Lett; 1988 Nov; 19(3):223-7. PubMed ID: 3069709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients.
    Kaplan G; Laal S; Sheftel G; Nusrat A; Nath I; Mathur NK; Mishra RS; Cohn ZA
    J Exp Med; 1988 Nov; 168(5):1811-24. PubMed ID: 3053962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Kaplan G; Sheftel G; Job CK; Mathur NK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5210-4. PubMed ID: 2969108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
    Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
    Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular leprosy of childhood and tuberculoid leprosy: a comparative, morphologic, immunopathologic and quantitative study of skin tissue reaction.
    Fakhouri R; Sotto MN; Manini MI; Margarido LC
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):218-26. PubMed ID: 14608817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy.
    Damasco MH; Sarno EN; Lobão AS; Alvarenga FB; Porto JA; Rosankaimer F; Kaplan G
    Braz J Med Biol Res; 1992; 25(5):457-65. PubMed ID: 1342221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
    Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inside the skin: the local immune and inflammatory milieu in leprosy.
    Scollard DM
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
    Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
    J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of the lepromatous skin biopsy.
    Massone C; Belachew WA; Schettini A
    Clin Dermatol; 2015; 33(1):38-45. PubMed ID: 25432809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for IL-12 receptor expression and signal transduction in host defense in leprosy.
    Kim J; Uyemura K; Van Dyke MK; Legaspi AJ; Rea TH; Shuai K; Modlin RL
    J Immunol; 2001 Jul; 167(2):779-86. PubMed ID: 11441083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.
    Schlienger K; Uyemura K; Jullien D; Sieling PA; Rea TH; Linsley PS; Modlin RL
    J Immunol; 1998 Sep; 161(5):2407-13. PubMed ID: 9725237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy reactions. New knowledge.
    Naafs B
    Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.